Recent Patents on Anti-Cancer Drug Discovery
Title:Meet Our Associate Editorial Board Member
Volume: 16 Issue: 1
Author(s): Shanzhi Wang
Affiliation:
Export Options
About this article
Cite this article as:
Wang Shanzhi , Meet Our Associate Editorial Board Member, Recent Patents on Anti-Cancer Drug Discovery 2021; 16 (1) . https://dx.doi.org/10.2174/157489281601210324142135
DOI https://dx.doi.org/10.2174/157489281601210324142135 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
Call for Papers in Thematic Issues
Novel anti-cancer drugs in photoimmunotherapy management: from bench to translational research
In recent years, traditional cancer treatments, such as surgery, chemotherapy, and radiation treatment, etc., may damage the pathological tissue and normal cells. The ideal tumor treatment should be noninvasive, eliminating the primary tumor, making the body produce systemic tumor-specific immunity, eliminating metastases, and having less /no side effects. Recent Patents ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelets as Potential Immunomodulators: Is There a Role for Platelet Toll-Like Receptors?
Current Immunology Reviews (Discontinued) Attenuation of Lipopolysaccharide-induced Liver Injury by Bone Marrow Mesenchymal Stem Cells via Inhibiting the NLRP3 Inflammasome and Hepatocyte Pyroptosis
Current Stem Cell Research & Therapy The Novel Use of Lipids as Diagnostic Tools and Therapeutics in Cancer: Recent Insights and Challenges
Current Drug Targets Incretins and Preservation of Endothelial Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Insulin-Like Growth Factor-1, a Potential Predicative Biomarker for Postoperative Delirium Among Elderly Patients with Open Abdominal Surgery
Current Pharmaceutical Design Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to "Cool" the Heart
Medicinal Chemistry Potential Therapeutic Applications of C-Phycocyanin
Current Drug Metabolism Assessment of Hupu Gum for Its Carrier Property in the Design and Evaluation of Solid Mixtures of Poorly Water Soluble Drug - Rofecoxib
Current Drug Delivery Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Current Medicinal Chemistry Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
Current Topics in Medicinal Chemistry The Apoptotic Pathway as a Therapeutic Target in Sepsis
Current Drug Targets p53 is an Important Regulator of CCL2 Gene Expression
Current Molecular Medicine Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice
Current Drug Metabolism From Fragment Screening to Potent Binders: Strategies for Fragment-to-Lead Evolution
Mini-Reviews in Medicinal Chemistry Editorial [ Hot Topic:RIPpers at the Membrane – A Brief History of APP Secretases, their Substrates and their Functions (Guest Editors: Dieter Hartmann)]
Current Alzheimer Research Vascular Remodelling and Angiogenesis in Asthma: Morphological Aspects and Pharmacological Modulation
Inflammation & Allergy - Drug Targets (Discontinued) RNAi in Plasmodium
Current Pharmaceutical Design <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Tailoring Small Proteins Towards Biomedical Applications
Current Pharmaceutical Biotechnology Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design